From: Temporal dynamics of Mycobacterium tuberculosis genotypes in New South Wales, Australia
Category | Year | Total | ||
---|---|---|---|---|
2010 | 2011 | 2012 | n (%) | |
Gender | Â | Â | Â | Â |
   Male | 219 (61.3) | 219 (59.0) | 188 (53.6) | 626 (58.0) |
Age group | Â | Â | Â | Â |
   <15 years | 4 (1.1) | 5 (1.3) | 6 (1.7) | 15 (1.4) |
   15-29 years | 99 (27.7) | 94 (25.3) | 102 (29.1) | 295 (27.3) |
   30-44 years | 110 (30.8) | 116 (31.3) | 102 (29.1) | 328 (30.4) |
   45-59 years | 63 (17.6) | 60 (16.2) | 48 (13.7) | 171 (15.8) |
   ≥60 years | 81 (22.7) | 96 (25.9) | 93 (26.5) | 270 (25.0) |
Site of disease | Â | Â | Â | Â |
   Respiratory | 258 (72.3) | 260 (70.1) | 241 (68.7) | 759 (70.3) |
   Non-respiratory | 99 (27.7) | 111 (29.9) | 110 (31.3) | 320 (29.7) |
Strain family | Â | Â | Â | Â |
   Beijing | 93 (26.1) | 108 (29.1) | 97 (27.6) | 298 (27.6) |
   East African Indian | 112 (31.4) | 101 (27.2) | 95 (27.1) | 308 (28.5) |
   Delhi/CAS | 47 (13.2) | 53 (14.3) | 49 (14.0) | 149 (13.8) |
   LAM | 25 (7.0) | 14 (3.8) | 22 (6.3) | 61 (5.7) |
   Haarlem | 13 (3.6) | 21 (5.7) | 24 (6.8) | 58 (5.4) |
   Other | 67 (18.8) | 74 (19.9) | 64 (18.2) | 205 (19.0) |
Drug resistance | Â | Â | Â | Â |
   Isoniazid mono-resistance | 21 (5.9) | 23 (6.2) | 29 (8.3) | 73 (6.8) |
   Multi- or extremely drug resistant (M/XDR) | 7 (2.0) | 6 (1.6) | 5 (1.4) | 18 (1.7) |
Total | 357 (100) | 371 (100) | 351 (100) | 1079 (100) |